Physician profile
Cortney E Patrick
NPI 1295226728
$9,638.26
in general payments reported to CMS, 2019-2025
19 companies · $114 in 2025
The $114 reported for 2025 was less than what a typical Obstetrics & Gynecology (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,052 · 2022: $4,978 · 2023: $1,190 · 2024: $305 · 2025: $114.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,045 · Food and Beverage: $563.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,045.00 |
| Food and Beverage | $563.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $7,907.18 | 2021-2023 | Nexplanon |
| Abbvie INC. | $429.42 | 2021-2024 | |
| Galderma Laboratories, L.P. | $225.10 | 2022-2025 | |
| Jazz Pharmaceuticals INC. | $213.89 | 2022-2024 | |
| Mayne Pharma Commercial LLC | $188.82 | 2021-2022 | |
| Myovant Sciences INC. | $156.26 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $91.45 | 2024-2025 | Dupixent |
| Merck Sharp & Dohme LLC | $81.56 | 2021 | |
| Revance Therapeutics, INC. | $59.94 | 2025 | Daxxify |
| Novo Nordisk INC | $45.22 | 2021 | |
| Lupin INC. | $42.09 | 2021 | |
| Avion Pharmaceuticals | $35.82 | 2021 | |
| Mylan Pharmaceuticals INC. | $34.04 | 2021 | |
| Glaxosmithkline, LLC. | $32.15 | 2023 | Nucala |
| Agile Therapeutics, INC. | $25.32 | 2021-2023 | Twirla |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Idorsia Pharmaceuticals US INC | $20.71 | 2023 | Quviviq |
| Hikma Pharmaceuticals USA | $16.78 | 2024 | Ryaltris |
| Therapeuticsmd, INC. | $16.29 | 2021 | |
| Exeltis, USA INC. | $16.22 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cortney Patrick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.